2021 JSCNP指南:精神分裂症的药物治疗

2021-08-12 日本临床神经精神药理学学会 Neuropsychopharmacol

2021年8月,日本临床神经精神药理学学会(JSCNP)发布了精神分裂症的药物治疗指南。

中文标题:

2021 JSCNP指南:精神分裂症的药物治疗

英文标题:

Japanese Society of Neuropsychopharmacology: "Guideline for Pharmacological Therapy of Schizophrenia"

发布日期:

2021-08-12

简要介绍:

2021年8月,日本临床神经精神药理学学会(JSCNP)发布了精神分裂症的药物治疗指南。该指南主要包括5部分内容,分别为首发精神分裂症的管理,复发精神分裂症的管理,维持治疗,难治性疾病的治疗以及其他临床问题。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021JSCNP指南:精神分裂症的药物治疗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=48eae1c002210a84, title=2021 JSCNP指南:精神分裂症的药物治疗, enTitle=Japanese Society of Neuropsychopharmacology: "Guideline for Pharmacological Therapy of Schizophrenia", guiderFrom=Neuropsychopharmacol, authorId=0, author=, summary=2021年8月,日本临床神经精神药理学学会(JSCNP)发布了精神分裂症的药物治疗指南。, cover=https://img.medsci.cn/20211016/1634394379707_5579292.jpg, journalId=0, articlesId=null, associationId=2016, associationName=日本临床神经精神药理学学会, associationIntro=日本临床神经精神药理学学会(JSCNP,Japanese Society of Clinical Neuropsychopharmacology), copyright=0, guiderPublishedTime=Thu Aug 12 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年8月,日本临床神经精神药理学学会(JSCNP)发布了精神分裂症的药物治疗指南。该指南主要包括5部分内容,分别为首发精神分裂症的管理,复发精神分裂症的管理,维持治疗,难治性疾病的治疗以及其他临床问题。</span></p>, tagList=[TagDto(tagId=1344, tagName=精神分裂症)], categoryList=[CategoryDto(categoryId=13, categoryName=精神心理科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=1344, guiderKeyword=精神分裂症, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=5, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6353, appHits=270, showAppHits=0, pcHits=2261, showPcHits=6082, likes=0, shares=21, comments=3, approvalStatus=1, publishedTime=Sat Oct 16 22:29:55 CST 2021, publishedTimeString=2021-08-12, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Sat Oct 16 22:28:47 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 21:10:04 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021JSCNP指南:精神分裂症的药物治疗.pdf)])
2021JSCNP指南:精神分裂症的药物治疗.pdf
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2178784, encodeId=c34c21e878406, content=药物治疗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bfc9129690, createdName=ms8000000007334279, createdTime=Tue Jan 02 14:50:11 CST 2024, time=2024-01-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1216137, encodeId=f1ed121613ebb, content=<a href='/topic/show?id=c9bfe649471' target=_blank style='color:#2F92EE;'>#精神分裂症#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76494, encryptionId=c9bfe649471, topicName=精神分裂症)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sun May 01 19:09:33 CST 2022, time=2022-05-01, status=1, ipAttribution=)]
    2024-01-02 ms8000000007334279 来自四川省

    药物治疗

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2178784, encodeId=c34c21e878406, content=药物治疗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bfc9129690, createdName=ms8000000007334279, createdTime=Tue Jan 02 14:50:11 CST 2024, time=2024-01-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1216137, encodeId=f1ed121613ebb, content=<a href='/topic/show?id=c9bfe649471' target=_blank style='color:#2F92EE;'>#精神分裂症#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76494, encryptionId=c9bfe649471, topicName=精神分裂症)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sun May 01 19:09:33 CST 2022, time=2022-05-01, status=1, ipAttribution=)]

拓展阅读

WFSBP 精神分裂症的生物学治疗指南,第2部分:精神分裂症的长期治疗和抗精神病药物副作用的管理(2012年更新)

世界生物精神病学会联合会(WFSBP,World Federation of Societies of Biological Psychiatry) · 2012-12-06

2016 RANZCP临床实践指南:精神分裂症及其相关疾病的管理

澳大利亚与新西兰皇家精神科医师学会(RANZCP,Royal Australian and New Zealand college of Psychiatrists) · 2016-04-27

2019 BAP循证指南:精神分裂症的药物治疗(更新版)

英国精神药理协会(BAP,British Association for Psychopharmacology) · 2019-12-12

精神分裂症患者代谢综合征管理的中国专家共识

中华医学会精神病学分会 · 2020-01-30

2020 APA实践指南:精神分裂症的治疗(第3版)

美国精神病学会(APA,American Psychiatric Association) · 2020-09-01